课题基金 / 基金详情

Search for the new target points of bisphosphonates in bone cells: Their inhibitory actions on bone resorption and the stimulatory actions on bone formation

Search for the new target points of bisphosphonates in bone cells: Their inhibitory actions on bone resorption and the stimulatory actions on bone formation
寻找双膦酸盐在骨细胞中的新靶点:其对骨吸收的抑制作用和对骨形成的刺激作用
批准号:
13470391
负责人:
OHYA Keiichi
金额:
$8.77万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2003

项目摘要

项目成果

OHYA Keiichi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Bisphosphonates have been found as an analogue compound of pyrophosphates. They have a strong affinity for binding bone and show a strong inhibitory action on bone resorption. Recently their actions for osteoclast function have been clarified, but our previous studies indicate that other actions of bisphosphonate might be related with the pharmacological effects on bone tis-sue. We focused to find the new targets of the drug and performed the present research. In vivo studies demonstrated that the decrease of bone mineral density induced by the low-calcium feeding in rats was inhibited by the treatments of bisphosphonate. At the same time, bisphos-phonate significantly stimulated the mineral apposition rate of bone formation surface. In in vitro study, the mineralized nodule formation was increased by bisphosphonate in bone marrow cell culture and this effect might be accompanied with the progress of osteoblast differentiation. The-se results indicated that the action of bisphosphonates on bone tissues is the combined effects of the inhibitory actions on bone resorption and the stimulatory actions on bone formation. In addition, bisphosphonate blocked the bone resorption induced by the inoculation of Walker256/s mammary carcinoma cells in rats. Because the bone resorption in this carcinoma bearing rats is due to the inhibition of the estrogen synthesis induced by the LH-RH system, the present inhibi-tory effects of bisphosphonate on the experimental rats indicated the usefulness of the drug for the treatment of this type of disease From these results, the new targets points of bisphospho-nates both on the osteoclasts and osteoblasts are clarified and these targets of bisphosphonates are important to understand the actions of the drug on bone tissues.
期刊论文(20)
专著(0)
科研奖励(0)
会议论文
D.Hone, M.Takahashi, K.Aoki, K.Ohya: "Clodronate Stimulates Bone Formation as well as Inhibits Bone Resorption and Increases Bone Mineral Density in Rats Fed a Low-Calcium Diet."Journal of Medical and Dental Science.. 50. 121-132 (2003)
D.Hone、M.Takahashi、K.Aoki、K.Ohya:“氯膦酸盐刺激低钙饮食大鼠的骨形成、抑制骨吸收并增加骨矿物质密度。”医学和牙科科学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
D Horie, M Takahashi, K Aoki, K, Ohya: "Clodronate Stimulates Bone Formation as well as Inhibits Bone Resorption and Increases Bone Mineral Density in Rats Fed a Low-Calcium Diet."Journal of Medical and Dental Sciences. 50. 121-132 (2003)
D Horie、M Takahashi、K Aoki、K、Ohya:“氯膦酸盐刺激低钙饮食大鼠的骨形成、抑制骨吸收并增加骨矿物质密度。”医学和牙科科学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
E.Takahashi, H.Mukohyama, K.Aoki, W.R.Duarte, U.H.Lerner, K.Ohya, K.Omura, S.Kasugai: "High Extracellular Calcium Affects Osteoclastogenesis in Mouse Bone Marrow Cell Culture."Journal of Medical and Dental Sciences.. 49(4). 109-120 (2002)
E.Takahashi、H.Mukohyama、K.Aoki、W.R.Duarte、U.H.Lerner、K.Ohya、K.Omura、S.Kasugai:“高细胞外钙影响小鼠骨髓细胞培养中的破骨细胞生成。”医学和牙科科学杂志
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
10
    New bone resrption inhibitor based on agonistic function for TNF type 2 receptor
    • 批准号:
      25670787
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2013
    • 负责人:
      OHYA Keiichi
    • 依托单位:
    Development of TNF-receptor Antagonists which have both Anti-inflammatory Action and Bone Formation Activity and Apply Them for the Treatment of Periodontal Diseases.
    • 批准号:
      24390413
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.73万
    • 财政年份:
      2012
    • 负责人:
      OHYA Keiichi
    • 依托单位:
    Development of new therapeutic drugs for inflammatory bone destruction by the CIAM compound, a new TNF receptor antagonist.
    • 批准号:
      19390471
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.48万
    • 财政年份:
      2007
    • 负责人:
      OHYA Keiichi
    • 依托单位:
    Development of New Hybrid-type Drugs Targeted to the Mechanism of Bone Remodeling
    • 批准号:
      16209053
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $31.12万
    • 财政年份:
      2004
    • 负责人:
      OHYA Keiichi
    • 依托单位:
    国内基金
    海外基金
    新型小分子蛋白—人肝细胞生长因子三环域(hHGFK1)抑制破骨细胞及治疗小鼠骨质疏松的疗效评估与机制研究
    • 批准号:
      82370885
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      姚晨
    • 依托单位:
    miRNA靶位点遗传多态性调控骨质疏松机理研究
    • 批准号:
      31071097
    • 项目类别:
      面上项目
    • 资助金额:
      36.0万元
    • 批准年份:
      2010
    • 负责人:
      雷署丰
    • 依托单位: